(MENAFN- Ameliorate Digital Consultancy) The market for flowable hemostats is anticipated to reach US$ 1,124 million in fiscal year 2022, up from US$ 912.2 million in fiscal year 2021. From 2022 to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback